EUVIMEDEUVIMED entdecken
Crossref

Molecular insights into SMARCA2 degradation in SMARCA4-mutant lung cancers

Kostas A Papavassiliou, Nektarios Anagnostopoulos, Athanasios G Papavassiliou

Trends in Cancer · 2025

DOI: 10.1016/j.trecan.2025.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Cancer, 2025. Verfasst von Kostas A Papavassiliou und 2 weiteren Autor:innen. Beteiligte Einrichtung: First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, Athens…. Hauptthemen laut MEDLINE: Lung Neoplasms, Transcription Factors, DNA Helicases, Nuclear Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The molecular mechanisms of switch/sucrose nonfermentable (SWI/SNF)-related BAF chromatin remodeling complex subunit ATPase 2 (SMARCA2) degradation remain elusive. Recently, Kotagiri et al. revealed that SMARCA2 degradation induces enhancer reprogramming in SMARCA4-mutant lung cancer cells, rendering enhancers of key cell-cycle genes inaccessible and suppressing their expression. In addition, the authors identified that transcriptional enhanced associate domain (TEAD) inhibitors synergize with SMARCA2 degraders in inhibiting SMARCA4-mutant lung cancer growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsTranscription FactorsDNA HelicasesNuclear ProteinsHumansMutationGene Expression Regulation, NeoplasticProteolysisCell Line, TumorAnimals

Stichwörter der Autor:innen

SMARCA2 degraderSMARCA4-mutant cancersTEAD inhibitorchromatin accessibilityenhancer reprogramminglung cancer

Substanzen

SMARCA4 protein, humanTranscription FactorsSMARCA2 protein, humanDNA HelicasesNuclear Proteins

Autor:innen und Institutionen

  • First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
  • Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece. Electronic address: papavas@med.uoa.gr.

Zitieren

APA

Papavassiliou, K. A., Anagnostopoulos, N., & Papavassiliou, A. G. (2025). Molecular insights into SMARCA2 degradation in SMARCA4-mutant lung cancers. Trends in Cancer. https://doi.org/10.1016/j.trecan.2025.02.002

Vancouver

Papavassiliou KA, Anagnostopoulos N, Papavassiliou AG. Molecular insights into SMARCA2 degradation in SMARCA4-mutant lung cancers. Trends in Cancer. 2025. doi:10.1016/j.trecan.2025.02.002

BibTeX
@article{Papavassiliou2025,
  author = {Papavassiliou, Kostas A and Anagnostopoulos, Nektarios and Papavassiliou, Athanasios G},
  title = {Molecular insights into SMARCA2 degradation in SMARCA4-mutant lung cancers},
  journal = {Trends in Cancer},
  year = {2025},
  doi = {10.1016/j.trecan.2025.02.002}
}
Kostenlos starten →